n-acetyllactosamine has been researched along with Stomach Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mare, L; Trinchera, M | 1 |
1 other study(ies) available for n-acetyllactosamine and Stomach Neoplasms
Article | Year |
---|---|
Suppression of beta 1,3galactosyltransferase beta 3Gal-T5 in cancer cells reduces sialyl-Lewis a and enhances poly N-acetyllactosamines and sialyl-Lewis x on O-glycans.
Topics: Adenocarcinoma; Amino Sugars; Base Sequence; Carbohydrate Sequence; Colonic Neoplasms; DNA Primers; DNA, Antisense; Galactose; Galactosyltransferases; Glycopeptides; Glycosylation; Humans; Molecular Sequence Data; Oligosaccharides; Polysaccharides; Promoter Regions, Genetic; Sialyl Lewis X Antigen; Stomach Neoplasms; Suppression, Genetic; Tumor Cells, Cultured | 2004 |